POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC
Clinical trials for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC trials appear
Sign up with your email to follow new studies for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough nerve disease: experimental drug riliprubart enters final testing
Disease control Recruiting nowThis study tests a drug called riliprubart in 140 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hasn't improved with standard care. Participants receive either riliprubart or a placebo for up to 111 weeks. The main goal is to see if the drug reduces di…
Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can digital tools better track disability in a rare nerve disease? a new study aims to find out.
Knowledge-focused Recruiting nowThis observational study follows about 200 people in the United States who have chronic inflammatory demyelinating polyneuropathy (CIDP) and still experience disability despite at least three months of standard treatment. Researchers will track changes in disability scores and ex…
Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC